Valacyclovir hydrochloride and Actonel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valacyclovir hydrochloride (valacyclovir hydrochloride) and Actonel (risedronate sodium). Common drug interactions include osteonecrosis of jaw among females and interstitial lung disease among males.

The phase IV clinical study analyzes what interactions people have when they take Valacyclovir hydrochloride and Actonel. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Valacyclovir hydrochloride?

Valacyclovir hydrochloride has active ingredients of valacyclovir hydrochloride. It is often used in herpes zoster. eHealthMe is studying from 12,929 Valacyclovir hydrochloride users. Check the latest studies of Valacyclovir hydrochloride.

What is Actonel?

Actonel has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 29,369 Actonel users. Check the latest studies of Actonel.



On Jul, 14, 2026

40 people who take Valacyclovir hydrochloride and Actonel together, and have interactions are studied.

Valacyclovir hydrochloride and Actonel drug interactions.

What are the common drug interactions of Valacyclovir Hydrochloride and Actonel, by gender? *:

female:

  1. Osteonecrosis of jaw (death of bone of jaw)
  2. Oral herpes (viral infection of mouth)
  3. Periodontitis (inflammation of the tissue around the teeth)
  4. Gastroenteritis (inflammation of stomach and intestine)
  5. Periodontal disease (disease that attacks the gum and bone and around the teeth)
  6. Necrosis (the death of body tissue)
  7. Gingival ulceration (ulcer on gums)
  8. Oral pain
  9. Pain in jaw
  10. C-reactive protein increased

male:

  1. Interstitial lung disease
  2. Blood pressure increased
  3. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  4. Escherichia sepsis (bacterial infection by escherichia coli)
  5. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  6. Infusion related reaction
  7. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  8. Septic shock (shock due to blood infection)
  9. Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
  10. Glaucoma (increased fluid pressure in the eye with vision loss)

What are the common drug interactions of Valacyclovir Hydrochloride and Actonel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Renal impairment (severely reduced kidney function)
  2. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  3. Escherichia sepsis (bacterial infection by escherichia coli)
  4. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  5. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  6. Septic shock (shock due to blood infection)
  7. Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)

60+:

  1. Oral herpes (viral infection of mouth)
  2. Osteonecrosis of jaw (death of bone of jaw)
  3. C-reactive protein increased
  4. Confusional state
  5. Dyspnoea (difficult or laboured respiration)
  6. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  7. Partial seizures (seizures which affect only a part of the brain at onset)
  8. Hepatic enzyme increased
  9. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  10. Loss of consciousness

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 37.50%
  2. High Blood Pressure: 14 people, 35.00%
  3. Oral Herpes (viral infection of mouth): 12 people, 30.00%
  4. Polyarthritis (arthritis which involves 5 or more joints simultaneously): 11 people, 27.50%
  5. Headache (pain in head): 4 people, 10.00%
  6. Genital Herpes (herpes infection of genital): 4 people, 10.00%
  7. Depression: 4 people, 10.00%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 10.00%
  9. Vasculitis Necrotising (inflammation and damage to blood vessels): 2 people, 5.00%
  10. Multiple Myeloma (cancer of the plasma cells): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Valacyclovir hydrochloride and Actonel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valacyclovir hydrochloride and Actonel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valacyclovir hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Actonel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actonel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on valacyclovir hydrochloride and risedronate sodium (the active ingredients of Valacyclovir hydrochloride and Actonel, respectively), and Valacyclovir hydrochloride and Actonel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: